Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f9e708e8e4a94657bdc8e388bc81fd42 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f9e708e8e4a94657bdc8e388bc81fd422021-12-02T17:42:11ZPre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging10.1038/s41467-020-18405-92041-1723https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd422020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18405-9https://doaj.org/toc/2041-1723Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits.Joseph FloresAnastasia NoëlBénédicte FoveauOlivier BeauchetAndréa C. LeBlancNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Joseph Flores Anastasia Noël Bénédicte Foveau Olivier Beauchet Andréa C. LeBlanc Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
description |
Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits. |
format |
article |
author |
Joseph Flores Anastasia Noël Bénédicte Foveau Olivier Beauchet Andréa C. LeBlanc |
author_facet |
Joseph Flores Anastasia Noël Bénédicte Foveau Olivier Beauchet Andréa C. LeBlanc |
author_sort |
Joseph Flores |
title |
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
title_short |
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
title_full |
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
title_fullStr |
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
title_full_unstemmed |
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging |
title_sort |
pre-symptomatic caspase-1 inhibitor delays cognitive decline in a mouse model of alzheimer disease and aging |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd42 |
work_keys_str_mv |
AT josephflores presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging AT anastasianoel presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging AT benedictefoveau presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging AT olivierbeauchet presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging AT andreacleblanc presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging |
_version_ |
1718379682320089088 |